Study finds new clues in eye cancer

Published:

About five per cent of melanomas in the eye are caused by exposure to sunlight, while the majority are not, a new study by QIMR Berghofer and Queensland Ocular Oncology Service has found.

The findings indicate this cancer – uveal melanoma – is made up of a number of subclasses and could explain why it is difficult to treat.

Uveal melanoma (also known as eye or ocular melanoma) is relatively rare. About 175 new cases are diagnosed in Australia annually.

Many patients will lose an eye or sight as part of their treatment, and the cancer will spread to other parts of the body for almost half the patients.

Co-lead author and head of QIMR Berghofer’s Oncogenomics group, Professor Nick Hayward, said the researchers also discovered that a common anti-cancer gene, named TP53, was often switched off in uveal melanoma.

“We hadn’t known the role of the TP53 gene in uveal melanoma before this study, so our findings open up new avenues for potential treatments for this disease,” Professor Hayward said.

“Identifying that this anti-cancer gene is turned off in some uveal melanomas improves our understanding of how the tumours develop and may provide a target for new treatments.”

The researchers sequenced the entire genomes of more than 100 patients with uveal melanoma and compared the data on DNA mutations with their health outcomes.

Co-lead author, ophthalmologist and Director of Queensland Ocular Oncology Service, Associate Professor Bill Glasson, said uveal melanoma was hard to treat, particularly when it metastasised.

“Understanding that uveal melanoma is made up of a number of mutational subclasses explains why patients respond so differently to treatments,” Associate Professor Glasson said.

“We found that tumours in the iris have more mutations, which means they are potentially more suitable for immunotherapy since a high number of mutations has been shown to be a marker of response to immunotherapy in the treatment of metastatic skin melanomas.”

Joint first author and QIMR Berghofer researcher, Dr Peter Johansson, said the study looked at the total number and patterns of mutations to see if there were clues to how some of the tumours may have developed.

“We wanted to identify mutations in uveal melanomas that could be targeted with drugs and other treatments because the disease is highly resistant to current therapies,” he said.

“The study indicated the larger number of gene mutations in iris melanoma was predominantly caused by sunlight exposure. In contrast, there is no indication that sunlight plays a part in the majority of uveal melanomas which occur in the back of the eye.”

Dr Kelly Brooks, a researcher at QIMR Berghofer and joint first author of the study, said the findings added further weight to current general sun protection advice.

“This study confirms wearing sunglasses could help prevent up to five per cent of uveal melanoma cases,” she said.

“We now really need to turn our attention to better understand the details of how uveal melanoma develop, which will hopefully lead to new suitable drug targets for the other subclasses of uveal melanoma which make up 95 per cent of the disease.”

The study results have been published in the journal Nature Communications.

The work was partly funded by the Walking on Sunshine Foundation. One of its founders, Anne Stanton, passed away last year from uveal melanoma.

 
Community Health & Wellness Science & Research
Social:   

QIMR Berghofer Medical Research Institute :
PO Royal Brisbane Hospital, Brisbane, QLD, 4029, Brisbane
07 3845 3752
QIMR Berghofer Medical Research Institute
Showing 10+ recent articles for this business
Study finds new clues in eye cancer 19 May 2020 | About five per cent of melanomas in the eye are caused by exposure to sunlight, while the majority are not, a new study by QIMR Berghofer and Queensland Ocular Oncology Service has found. More information...
Queenslanders needed to help find potential COVID-19 immunotherapy treatment 14 May 2020 | QIMR Berghofer scientists are urging Queenslanders who have recovered from COVID-19 to help them discover how the human immune system fights the disease – and hopefully develop immunotherapies to treat very sick... More information...
Scientists to trial rheumatoid arthritis drug in ICU patients with COVID-19 09 May 2020 | Queensland researchers are preparing to begin a clinical trial of a drug that regulates inflammation in the hope it may help save the lives of critically ill patients with COVID-19. More information...
Scientists double understanding of genetic risk of melanoma 28 April 2020 | A global collaboration of scientists has more than doubled the known number of regions on the human genome that influence the risk of developing melanoma. More information...
Breastfeeding linked to lower ovarian cancer risk 03 April 2020 | An international study involving researchers from QIMR Berghofer Medical Research Institute has found women who breastfeed their babies may lower their risk of developing ovarian cancer by almost 25 per cent. More information...
QIMR Berghofer fast tracks vital coronavirus research 25 March 2020 | A $1 million donation from Queensland philanthropist Clive Berghofer AM will help boost a wide-ranging research program at QIMR Berghofer into the global pandemic, COVID-19. More information...
Global collaboration predicts nearly 200 genes that affect breast cancer risk 27 February 2020 | An international study, co-led by Queensland researchers, has concluded that 191 genes are likely to affect a woman’s risk of developing breast cancer. More information...
Snoring is in your genes 15 February 2020 | A new study by QIMR Berghofer Medical Research Institute has identified 173 genes linked to snoring and confirmed overweight, middle-aged men who smoke are the most likely to have the sleep condition. More information...
Scientists develop test that will help prevent glaucoma-related blindness 21 January 2020 | Australian researchers have identified 107 genes that increase a person’s risk of developing the eye disease glaucoma, and developed a genetic test to detect those at risk of going blind from it. More information...


comments powered by Disqus

All articles submitted by third parties or written by My Sunshine Coast come under our Disclaimer / Terms of Service